Hot News : LyondellBasell Industries N.V. (NYSE:LYB), Aruba Networks, Inc. (NASDAQ:ARUN), ERBA Diagnostics, Inc. (NYSEMKT:ERB), Penn National Gaming Inc. (NASDAQ:PENN), UCP, Inc. (NYSE:UCP)

On Oct 24, LyondellBasell Industries N.V. (NYSE:LYB), said “tight” markets for its products may stall the narrower margins that it expects will ultimately come from lower oil prices. Third-quarter net income rose to $2.45 a share from $1.50 a year earlier. Profit excluding some items was $2.51, exceeding the $2.30 average of 18 analysts’ estimates compiled by Bloomberg. LyondellBasell Industries N.V. (NYSE:LYB) belongs to Basic … Continue reading Hot News : LyondellBasell Industries N.V. (NYSE:LYB), Aruba Networks, Inc. (NASDAQ:ARUN), ERBA Diagnostics, Inc. (NYSEMKT:ERB), Penn National Gaming Inc. (NASDAQ:PENN), UCP, Inc. (NYSE:UCP)

Shining on Major News : Amgen Inc. (NASDAQ:AMGN), Digi International Inc. (NASDAQ:DGII), Meritage Homes Corporation (NYSE:MTH), ERBA Diagnostics, Inc. (NYSEMKT:ERB), WESCO International (NYSE:WCC)

On SEP 5, Amgen Inc. (NASDAQ:AMGN) will participate in the Morgan Stanley Global Healthcare Conference on Wednesday, Sept. 10, 2014, at the Grand Hyatt New York in New York City, beginning at 9:10 a.m. ET. Robert A. Bradway, chairman and chief executive officer at Amgen, will present at the conference.  Amgen Inc. (NASDAQ:AMGN) belongs to Healthcare sector. Its net profit margin is 25.70% and weekly … Continue reading Shining on Major News : Amgen Inc. (NASDAQ:AMGN), Digi International Inc. (NASDAQ:DGII), Meritage Homes Corporation (NYSE:MTH), ERBA Diagnostics, Inc. (NYSEMKT:ERB), WESCO International (NYSE:WCC)

Healthcare Losers: Cara Therapeutics (NASDAQ:CARA), ERBA Diagnostics Inc (NYSEMKT:ERB), Actinium Pharmaceuticals Inc (NYSEMKT:ATNM), Concert Pharmaceuticals (NASDAQ:CNCE)

Cara Therapeutics Inc (NASDAQ:CARA) — which has a preclinical cannabis compound — jumped 11.58%. The company is clearly running (smoke) rings around the competition and has the most appropriately named spokeswoman on Earth should it wish to employ the English supermodel as a mouthpiece. Cara Therapeutics Inc (NASDAQ:CARA) stock performance was -7.49% in last session and finished the day at $14.20. Traded volume was 123,773.00million … Continue reading Healthcare Losers: Cara Therapeutics (NASDAQ:CARA), ERBA Diagnostics Inc (NYSEMKT:ERB), Actinium Pharmaceuticals Inc (NYSEMKT:ATNM), Concert Pharmaceuticals (NASDAQ:CNCE)